Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Leukemia|May 1, 1990
IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferationN Onetto-Pothier, N Aumont, A Haman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracilS E O'Reilly, K A Gelmon, N Onetto, et al.Seminars in Oncology|August 1, 1995
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancerV Dieras, M Marty, N Tubiana, et al.Seminars in Oncology|December 1, 1992
Drug discovery and development in the pharmaceutical industryL P Schacter, C Anderson, R M Canetta, et al.Blood|January 1, 1990
Characterization of granulocyte-macrophage colony-stimulating factor receptor on the blast cells of acute myeloblastic leukemiaN Onetto-Pothier, N Aumont, A Haman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancerA W Tolcher, S Sugarman, K A Gelmon, et al.Blood|May 15, 1992
Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donorsJ Nemunaitis, C Anasetti, R Storb, et al.Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trialJ S Abrams, D A Vena, J Baltz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Successful re-treatment with taxol after major hypersensitivity reactionsD M Peereboom, R C Donehower, E A Eisenhauer, et al.Pageof 3